Establishment of an antimicrobial stewardship strategy on the surgical NICU at Cairo University specialized pediatric hospital

• Published in: Journal of pediatric surgery Vol. 55; no. 9; pp. 1959 - 1964
• Main Authors: Bassiouny, Dina M., Hassan, Reem M., Shalaby, Aly, Halim, Mona M.A., Wassef, Mona A.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-09-2020
• Subjects: Antimicrobial Stewardship; Egypt; Hospitals, Pediatric; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Neonate; Operating Rooms; Prospective Studies; Surgical site infection; Egypt; Surgical site infection; Antimicrobial stewardship; Neonate
• ISSN: 0022-3468; 1531-5037
• DOI: 10.1016/j.jpedsurg.2019.12.005

Antimicrobial resistance is a major concern that we are facing nowadays. This is due to antibiotic misuse and bacteria developing resistance to the commonly used antibiotics. This may lead to increased mortality and consumption of country resources. Implementation of an antimicrobial stewardship program [ASP] can limit the use of unnecessary antibiotics and subsequently decrease the infection rates with better patient outcome. We aimed to control antibiotic misuse, reduce infection rate, decrease drug costs, and reduce length of hospital stay in the ICU.
We conducted a prospective study on the surgical neonatal ICU [SNICU] over a period of 6 months divided into pre-implementation phase, followed by an ASP phase, in which we applied the antibiotic guidelines approved by the ASP committee. Data were collected in the two phases and analyzed for demographics, compliance with guidelines, prescribed antibiotics, lab investigations, surgical site infection [SSI], length of stay and patient outcome.
Compliance to the guidelines was encountered in 86% and SSI rate decreased to 20%. Days of Therapy (DOT) per 1000 patient days showed a significant decrease in Ampicillin Sulbactam by 296 (p = 0.024), Imipenem by 220.34 (p = 0.024) and Vancomycin by 287.34 (p = 0.048). Drug cost showed a 1185.97 EGP decrease in the ASP period compared to the pre-implementation period (p = 0.714). Average LOS decreased in the ASP period by a mean difference of 2.5 (p = 0.027).
ASP implementation can control antibiotic misuse, decrease the medical care expenses and improve patient outcome.
Clinical research paper.
Level one.